logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Tatsunori Shimoi

national cancer center hospital

21H-index
354Paper Count
2.5KCitation Count
Published Papers 89
Publication Date
logo
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort
errCancer Science
IF4.3
err2026-08-18
err0
errOAAI
errMasashi Kanai; Kuniko Sunami; Tatsunori Shimoi; Satoshi Nishiwaki; Ichiro Kinoshita; Tetsuhiro Yoshinami; Chigusa Morizane; Yusuke Sato; Toshio Kubo; Mamoru Ito; Hiroshi Nishihara; Toru Mukohara; Hidekazu Shirota; Ryo Ko; Taro Shibata; Manabu Muto; Noboru Yamamoto
errShare
errSave
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer
errBreast Cancer Research and Treatment
IF3
err2026-06-22
err0
errOAAI
errYuhei Yamaguchi; Mai Hoshino; Tatsunori Shimoi; Hiroki Tamura; Yutaka Natori; Takuro Saiki; Taro Yamanaka; Rui Kitadai; Ayumi Saito; Shosuke Kita; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Akiko Miyagi Maeshima; Takeshi Murata; Shin Takayama; Yasuto Naoi; Kan Yonemori; Masayuki Yoshida
errShare
errSave
MTAP loss in advanced mucinous ovarian carcinoma: Prevalence, co-alteration patterns, and prognostic association in a nationwide Japanese genomic registry
errGynecologic Oncology
IF4.1
err2026-04-23
err0
PREAI
errTaro Yamanaka; Yuki Kojima; Jun Sato; Hiroki Tamura; Yutaka Natori; Takuro Saiki; Mai Hoshino; Ayumi Saito; Shosuke Kita; Aiko Maejima; Tatsunori Shimoi; Kazuki Sudo; Takafumi Koyama; Kan Yonemori
errShare
errSave
Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study
errJapanese Journal of Clinical Oncology
IF2.2
err2026-03-01
err0
PREAI
errYokoyama, Kazuki; Honda, Kazunori; Matsumoto, Kazuko; Ando, Yayoi; Ito, Munehiro; Goto, Rei; Shinno, Yuki; Shimoi, Tatsunori; Suzuki, Tatsuya; Yoshioka, Takashi; Ishiki, Hiroto
errShare
errSave
Bridging across the pacific: overview of the 33rd annual meeting of the Japanese breast cancer society
errBreast Cancer
IF2.9
err2025-12-29
err0
PREAI
errHiroki Kusama; Yoshiya Horimoto; Kayo Adachi; Yoichi Koyama; Kyoko Orimoto; Takahiko Kawate; Fuyo Kimura; Takako Komiya; Hiroshi Kaise; Kimito Yamada; Tatsunori Shimoi; Goro Kutomi; Kazuaki Takabe; Takashi Ishikawa
errShare
errSave
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer
errnpj Breast Cancer
IF7.6
err2025-11-28
err0
errOAAI
errShu Yazaki; Rui Kitadai; Yukihide Momozawa; Teruhiko Yoshida; Takashi Yamanaka; Sho Shiino; Chisako Yamauchi; Kenichi Harano; Motonobu Saito; Yosuke Hirotsu; Hisaki Aiba; Ryuji Hamamoto; Chikako Shimizu; Akihiko Shimomura; Tatsunori Shimoi; Kazuki Sudo; Masayuki Yoshida; Kuniko Sunami; Yuichi Shiraishi; Aya Kuchiba; Megumi Hori; Kota Katanoda; Sadaaki Takata; Ayumi Ogawa; Masahiro Torasawa; Akifumi Mochizuki; Yoko Shimada; Kengo Hiranuma; Erisa Fujii; Makoto Hirata; Yuji Yamashita; Takahiro Kogawa; Takeshi Murata; Saori Fujiwara; Yohei Miyagi; Hiroshi Nakagomi; Kazunoshin Tachibana; Koichi Matsuda; Yoshinori Murakami; Katsushi Tokunaga; Yosuke Kawai; Biobank Japan Project; Masao Omata; Tohru Ohtake; Akihiko Suto; Tatsuya Onishi; Yoichi Naito; Toshinari Yamashita; Kan Yonemori; Takashi Kohno; Kouya Shiraishi
errShare
errSave
Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire Survey
errCANCER CONTROL
IF0
err2025-10-01
err0
PREAI
errIkka, Tsunakuni; Hatta, Taichi; Katsumata, Noriyuki; Takayama, Tomoko; Shimoi, Tatsunori; Fujita, Misao
errShare
errSave
Real-world treatment outcomes of abemaciclib in older patients with HR+, HER2- metastatic breast cancer in Japan
errFuture Oncology
IF2.6
err2025-09-15
err0
errOAAI
errTatsunori Shimoi; Yoshinori Tanizawa; Long Jin; Nobuyuki Sekine; Takahiro Nakayama
errShare
errSave
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer
errBreast Cancer
IF2.9
err2025-07-28
err0
errOAAI
errMai Hoshino; Tatsunori Shimoi; Taro Yamanaka; Rui Kitadai; Munehiro Ito; Ayumi Saito; Shosuke Kita; Asuka Kawachi; Hitomi Sumiyoshi Okuma; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Emi Noguchi; Yasuhiro Fujiwara; Jun Kato; Kan Yonemori
errShare
errSave
Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer☆
errESMO Open
IF8.3
err2025-06-01
err0
errOAAI
errK. Yonemori; T. Shimoi; K. Yamamoto; T. Kogawa; S. Kitano; S. Kobayashi; K. Yanai; K. Yamaguchi; Y. Otake; S. Hojo; M. Ono
errShare
errSave
Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types
errPATHOLOGY INTERNATIONAL
IF3.4
err2025-05-16
err0
errOAAI
errRyoko Rikitake; Yasushi Yatabe; Yoko Yamamoto; Tatsunori Shimoi; Shintaro Iwata; Yasushi Goto; Yu Mizushima; Akira Kawai; Takahiro Higashi
errShare
errSave
Diagnosis and treatment of cardiac tumors
errMEDICAL ONCOLOGY
IF3.5
err2025-03-17
err0
errOAAI
errImai, Toru; Shimoi, Tatsunori; Kawai, Akira; Yonemori, Kan
errShare
errSave
Clinical outcome of treatment rechallenge with HER2directed antibody-drug conjugate in metastatic breast cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errAndo, M. M.; Shimoi, T.; Imai, T.; Kojima, Y.; Sudo, K.; Yonemori, K.
errShare
errSave
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
errBREAST CANCER
IF2.9
err2024-08-14
err2
errOAAI
errKitadai, Rui; Shimoi, Tatsunori; Yazaki, Shu; Okuma, Hitomi Sumiyoshi; Hoshino, Mai; Ito, Munehiro; Saito, Ayumi; Kita, Shosuke; Kojima, Yuki; Nishikawa, Tadaaki; Sudo, Kazuki; Noguchi, Emi; Fujiwara, Yasuhiro; Yoshida, Masayuki; Yonemori, Kan
errShare
errSave
Expression and co- expression patterns of TROP2 and HER2 in breast cancer: implications for bispecific antibody- drug conjugate therapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errOnishi, Mai; Shimoi, Tatsunori; Kojima, Yuki; Yazaki, Shu; Yamanaka, Taro; Kitadai, Rui; Kawachi, Asuka; Okuma, Hitomi; Hoshino, Mai; Saito, Ayumi; Ito, Munehiro; Maejima, Aiko; Nishikawa, Tadaaki; Sudo, Kazuki; Noguchi, Emi; Fujiwara, Yasuhiro; Yoshida, Masayuki; Yonemori, Kan
errShare
errSave
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2024-04-02
err28
PREAI
errLeon-Ferre, Roberto A.; Jonas, Sarah Flora; Salgado, Roberto; Loi, Sherene; de Jong, Vincent; Carter, Jodi M.; Nielsen, Torsten O.; Leung, Samuel; Riaz, Nazia; Chia, Stephen; Jules-Clement, Gerome; Curigliano, Giuseppe; Criscitiello, Carmen; Cockenpot, Vincent; Lambertini, Matteo; Suman, Vera J.; Linderholm, Barbro; Martens, John W. M.; van Deurzen, Carolien H. M.; Timmermans, A. Mieke; Shimoi, Tatsunori; Yazaki, Shu; Yoshida, Masayuki; Kim, Sung-Bae; Lee, Hee Jin; Dieci, Maria Vittoria; Bataillon, Guillaume; Vincent-Salomon, Anne; Andre, Fabrice; Kok, Marleen; Linn, Sabine C.; Goetz, Matthew P.; Michiels, Stefan
errShare
errSave
Clinical outcome of treatment rechallenge with HER2-directed antibody-drug conjugate in metastatic breast cancer: a single-centered real-world experience
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-03-01
err0
PREAI
errAndo, M.; Shimoi, T.; Imai, T.; Kojima, Y.; Sudo, K.; Yonemori, K.
errShare
errSave
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial
errECLINICALMEDICINE
IF10
err2024-03-01
err5
errOAAI
errShimoi, Tatsunori; Sunami, Kuniko; Tahara, Makoto; Nishiwaki, Satoshi; Tanaka, Shota; Baba, Eishi; Kanai, Masashi; Kinoshita, Ichiro; Shirota, Hidekazu; Hayashi, Hideyuki; Nishida, Naohiro; Kubo, Toshio; Mamesaya, Nobuaki; Ando, Yayoi; Okita, Natsuko; Shibata, Taro; Nakamura, Kenichi; Yamamoto, Noboru
errShare
errSave
Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services
errJOURNAL OF PAIN AND SYMPTOM MANAGEMENT
IF3.5
err2024-01-01
err2
errOAAI
errTagami, Keita; Chiu, Shih-Wei; Kosugi, Kazuhiro; Ishiki, Hiroto; Hiratsuka, Yusuke; Shimizu, Masaki; Mori, Masanori; Kubo, Emi; Ikari, Tomoo; Arakawa, Sayaka; Eto, Tetsuya; Shimoda, Mayu; Hirayama, Hideyuki; Nishijima, Kaoru; Ouchi, Kota; Shimoi, Tatsunori; Shigeno, Tomoko; Yamaguchi, Takuhiro; Miyashita, Mitsunori; Morita, Tatsuya; Inoue, Akira; Satomi, Eriko
errShare
errSave
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases
errMODERN PATHOLOGY
IF5.5
err2024-01-01
err6
PREAI
errOdate, Toru; Satomi, Kaishi; Kubo, Takashi; Matsushita, Yuko; Ueno, Toshihide; Kurose, Akira; Shomori, Kohei; Nakai, Tokiko; Watanabe, Reiko; Segawa, Keiko; Ohshika, Shusa; Miyake, Naritomo; Kudo, Sayaka; Shimoi, Tatsunori; Kobayashi, Eisuke; Komiyama, Motokiyo; Yoshimoto, Seiichi; Nakatani, Fumihiko; Kawai, Akira; Yatabe, Yasushi; Kohsaka, Shinji; Ichimura, Koichi; Ichikawa, Hitoshi; Yoshida, Akihiko
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
F
Fabrice André
H-index: 148 · Papers: 1.8K
S
Sherene Loi
H-index: 126 · Papers: 1.2K
G
Giuseppe Curigliano
H-index: 118 · Papers: 1.7K
Y
Yasushi Yatabe
H-index: 116 · Papers: 1.2K
A
Anne Vincent‐Salomon
H-index: 110 · Papers: 1.1K
View more